Gaëlle Asset

Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia

Eli M. Roth, James M. McKenney, Corinne Hanotin et al. · New England Journal of Medicine · 2012 · 464 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 380 citations

Medicine, Pharmacology, Pharmacotherapy +12

Effects of <i>Pinus pinaster</i> and <i>Pinus koraiensis</i> seed oil supplementation on lipoprotein metabolism in the rat

Gaëlle Asset, Bart Staels, Robert L. Wolff et al. · Lipids · 1999 · 85 citations

Life Sciences, Nutrition, Nutritional Sciences +17

Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design

Philippe Moreau, Meletios Α. Dimopoulos, Kwee Yong et al. · Future Oncology · 2019 · 71 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY

Ângelo Maiolino, Philippe Moreau, Meletios Α. Dimopoulos et al. · Hematology Transfusion and Cell Therapy · 2020 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13